| Vol. 16.15 – 20 April, 2022 |
| |
|
|
| Researchers analyzed single-cell whole-genome sequencing data from 319 neurons from the prefrontal cortex and hippocampus of individuals with Alzheimer’s disease and neurotypical control individuals. [Nature] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Investigators revealed brain-wide cellular reactions to type I interferon, an innate immune cytokine aberrantly elicited by amyloid β plaques, and examined their role in cognition and neuropathology relevant to Alzheimer’s disease in a murine amyloidosis model. [Immunity] |
|
|
|
| Scientists reported that the dormancy of quiescent neural stem cells was a therapeutic target for controlling the development of autism spectrum disorder phenotypes driven by Shank3 deficiency. [Molecular Psychiatry] |
|
|
|
| The authors reported that PTEN in primary sensory neurons was involved in processing itch and thermal information in adult mice. [Cell Reports] |
|
|
|
| Investigators revealed the regulatory mechanism of the SUR1 subunit and the role of ATP-sensitive potassium (KATP) channels in the progression of dopaminergic neuron degeneration. [Aging Cell] |
|
|
|
| The authors showed that NAD-dependent protein deacetylase sirtuin 2 (SIRT2) knockout was able to effectively ameliorate anomalous behavioral phenotypes in transgenic mouse models of Parkinson’s disease. [npj Parkinson’s Disease] |
|
|
|
| Scientists investigated the role of astrocytic Na+/H+ exchanger 1 in regulating reactive astrocyte lipocalin-2 (LCN2) secretion and neurodegeneration after stroke. [Cell Death & Disease] |
|
|
|
| In vitro studies using primary mouse cortical neurons showed that non-p-tau accumulated perinuclearly together with the tubulin after double-strand break induction with etoposide. [Communications Biology] |
|
|
|
| In glioma cells, depletion of guanylate-binding protein 2 (GBP2) impaired proliferation and migration, whereas overexpression of GBP2 enhanced proliferation and migration. [Cell Death Discovery] |
|
|
|
| Researchers evaluated the role of ubiquitin-specific protease 32 (USP32) in glioblastoma (GBM) progression and provided a potential target for GBM treatment. The clinical significance of USP32 was investigated using Gene Expression Omnibus databases. [Scientific Reports] |
|
|
|
|
| Investigators discuss recent advances in how neurons maintain a healthy pool of axonal mitochondria, as well as potential therapeutic strategies that target bioenergetic restoration to power neuronal survival, function, and regeneration. [Neuron] |
|
|
|
| The authors address the underlying mechanisms behind synaptic loss and dysfunction in Alzheimer’s disease and discuss potential strategies that target the synapse. [Molecular Psychiatry] |
|
|
|
|
| Neuraly announced the completion of patient enrollment in its Phase II study of NLY01 for Parkinson’s disease. [Neuraly, Inc. (Business Wire)] |
|
|
|
| Neuropore Therapies, Inc. announced that it received a $4.8M grant from The Michael J. Fox Foundation for Parkinson’s Research. The grant will be used to support the preclinical and clinical development of a novel brain-penetrating small molecule Toll-Like receptor 2 (TLR2) antagonist. [Neuropore Therapies, Inc.] |
|
|
|
|
| May 22 – 27, 2022 Lucca, Italy |
|
|
|
|
|
| Max Delbrück Center for Molecular Medicine – Berlin, Germany |
|
|
|
| University of California, San Diego – La Jolla, California, United States |
|
|
|
| University of California Los Angeles – Los Angeles, California, United States |
|
|
|
| University of Pittsburgh School of Medicine – Pittsburgh, Pennsylvania, United States |
|
|
|
| University of British Columbia – Vancouver, British Columbia, Canada |
|
|
|
|